Raloxifene Examined For Breast Cancer Prevention
Raloxifene Examined For Breast Cancer Prevention
|
An FDA advisory panel in July gave its stamp of approval for the osteoporosis drug raloxifene to be used as an oral chemopreventive agent for invasive breast cancer in older women at high risk for the disease and those with osteoporosis.However, that recommendation came with several qualifications. [click link for full article] |
read more...
News entry number 185 added on Sep 2, 2007 in the Health category.
Comenteaza
Other News in the Health category
Categorie:
Categorie:
3. ADEAGies Foundation Announces Inaugural William J. Gies Awards For Vision, Innovation, And Achieveme
Categorie:
Categorie:
Categorie:
Related Links
- Older women unaware of rising breast cancer risk
- More women face breast cancer risk
- Prostate Cancer Prevention Trial Study Reanalyzed
- LA BioMed Research Finds Simpler Way To Determine Breast Cancer Risk In Postmenopausal Women
- FDA Approves New Uses For Evista - Drug Reduces Risk Of Invasive Breast Cancer In Postmenopausal
- IPSOGEN And DNAVision Enter In Agreement To Offer In Vitro Diagnostic Tests For Breast Cancer
- Women stop taking breast cancer drugs due to aches and pains: study
- Early Diagnosis Of Prostate Cancer
- Progen Update On Phase 3 Clinical Program For PI-88 In Liver Cancer
News Categories
745
523
480
347
1011
693
280
973
Top 10 News
- Texas Woman Claims to Have Found Mythical 'Chupacabra'
- Google Starts Hosting News on Website
- Wireless technology hits security budgets
- Google forced to push image in China
- Western School Board limits digital devices
- 'Spooky' science points to quantum internet
- Nuñez, gov. gamble on healthcare overhaul
- Ho-hum, the guest's another candidate
- Study Focuses On Cancer Risk In Biologic Treatment For Rheumatoid Arthritis
- Microsoft purchase of RIM nice to consider, but unlikely
Statistics
News:
News Categories:
News Read:
News Categories:
News Read:
5052
8
609
8
609